STANDARD BIOTOOLS INC. — Director's Dealing 2014

Nov 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2014-11-17

Reporting Person: Smith William Maxwell (EVP, LEGAL AFFAIRS & GC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-17	Common Stock	M	2767	$4.4461	Acquired	3275	Direct
2014-11-17	Common Stock	M	233	$4.0828	Acquired	3508	Direct
2014-11-17	Common Stock	S	3000	$29.5242	Disposed	508	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-17	Employee Stock Option (Right to Buy)	$4.4461	M	2767	Disposed	2016-08-14	Common Stock (2767.0)	Direct
2014-11-17	Employee Stock Option (Right to Buy)	$4.0828	M	233	Disposed	2019-11-17	Common Stock (233.0)	Direct

Footnotes

F1: The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2013.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $29.52 to $29.556, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The shares subject to the Option fully vested on October 1, 2008.

F4: The shares subject to the Option fully vested on December 31, 2012.